Cited by 144Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsSingle-cell and spatial transcriptomics

Biomarkers to identify and isolate senescent cells

Open access
Matjusaitis, Mantas, Chin, Greg, Sarnoski, Ethan Anders, Stolzing, Alexandra·2016·Ageing Research Reviews

Abstract

Aging is the main risk factor for many degenerative diseases and declining health. Senescent cells are part of the underlying mechanism for time-dependent tissue dysfunction. These cells can negatively affect neighbouring cells through an altered secretory phenotype: the senescence-associated secretory phenotype (SASP). The SASP induces senescence in healthy cells, promotes tumour formation and progression, and contributes to other age-related diseases such as atherosclerosis, immune-senescence and neurodegeneration. Removal of senescent cells was recently demonstrated to delay age-related degeneration and extend lifespan. To better understand cell aging and to reap the benefits of senescent cell removal, it is necessary to have a reliable biomarker to identify these cells. Following an introduction to cellular senescence, we discuss several classes of biomarkers in the context of their utility in identifying and/or removing senescent cells from tissues. Although senescence can be induced by a variety of stimuli, senescent cells share some characteristics that enable their identification both in vitro and in vivo. Nevertheless, it may prove difficult to identify a single biomarker capable of distinguishing senescence in all cell types. Therefore, this will not be a comprehensive review of all senescence biomarkers but rather an outlook on technologies and markers that are most suitable to identify and isolate senescent cells.

Integrity signals

Registry

Crossref · 10.1016/j.arr.2016.05.003

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • No one marker alone is sufficient to identify senescence; most researchers use a panel of biomarkers, such as senescence-associated β-galactosidase, p21, and p16INK4A, combined with a marker of cellular proliferation.

    “No one marker alone is sufficient to identify senescence and most researchers use a panel of biomarkers, such as senescence-associated β-galactosidase, p21, and p16INK4A, as well as a number of other biomarkers, such as heterochromatin and proliferation markers (Table 1) combined [24] with a marker of cellular proliferation (Ki-67, for instance).”

Cites

1 retracted

Flagged first, then by citations

4 of the 177 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Matjusaitis, M., Chin, G., Sarnoski, E. A., & Stolzing, A.
Affiliations
  • University of Edinburgh (GB)
  • Yale University (US)
  • Loughborough University (GB)
Corresponding author
Stolzing, Alexandra
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2016-08
Volume
29
Pages
1-12
ISSN
1568-1637 (ISSN-L)
OpenAlex
W2397706209
Cited by
144
References
177
Citations by year
2026: 8 · 2025: 8 · 2024: 9 · 2023: 7 · 2022: 18 · 2021: 24 · 2020: 24 · 2019: 22 · 2018: 9 · 2017: 12 · 2016: 3
FWCI
1.80
Type
journal article
Language
en
Open access
Locations
  • Ageing Research Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • Loughborough University Institutional Repository (Loughborough University) (submittedVersion, cc-by-nc-nd)
  • Loughborough University Research Repository (Loughborough University) (submittedVersion, cc-by-nc-nd)
Funders
Bundesministerium für Bildung und Forschung (BMBF1315883)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
cellular senescence, senescence-associated secretory phenotype, senolytics, senolytic therapy, aging, age-related diseases, tissue dysfunction, immunosenescence, neurodegeneration, atherosclerosis
MeSH terms
Aging, Animals, Cell Separation, Humans, Neoplasms, Phenotype, Biomarkers, Cellular Senescence, Atherosclerosis, Cell- and Tissue-Based Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review